PK Study of Aripiprazole IM Depot for Chinese Patients With Schizophrenia
NCT03285503
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Schizophrenia
Interventions
DRUG:
Aripiprazole IM Depot
Sponsor
Otsuka Beijing Research Institute